Pharmacy
Medication Management Review Programs Fact Sheet
Information on the Medication Management Review Programs available under the Fourth Community Pharmacy Agreement.
Medication Management Review Programs Fact Sheet
The Fourth Community Pharmacy Agreement (Fourth Agreement) includes funding of up to $150 million for a range of Medication Management Review Programs. The Programs aim to enhance the Quality Use of Medicines, reduce the number of adverse drug events experienced by the elderly and others using multiple medicines, and assist them to manage their medicines.The services funded under the Medication Management Review Program are:
- Residential Medication Management Reviews;
- Home Medicine Reviews;
- Medication Review Accreditation Incentives; and
- Medication Management Review Facilitator Program.
Residential Medication Management Reviews
Residential Medication Management Reviews aim to improve the medication management for residents of aged care homes and to promote Quality Use of Medicines in residential aged care homes.Up to $67 million has been allocated for the Residential Medication Management Reviews program under the Fourth Agreement.
Approved aged care service providers employ accredited pharmacists to undertake medication reviews in residential aged care homes. The current payment arrangements include:
- a fee-for-service payment of $130 per review; and
- a requirement for Quality Use of Medicines services to be provided in residential aged care homes (with supporting documentation from service providers).
Home Medicines Reviews
The Home Medicines Review (HMR) program aims to enhance the Quality Use of Medicines, and reduce the number of adverse medicines events experienced by older Australians and others using multiple medications, by assisting them to manage their medicines.The Fourth Agreement provides up to $54 million for the HMR program. Of this funding, up to $10 million has been allocated to the Medication Review Accreditation Incentives program (see below for details).
Community pharmacies employ accredited pharmacists to conduct medication review interviews and collect medication information in the home, with the aim of reducing medication misadventure and optimising the benefits achieved from medication. As at January 2008, the fee paid to community pharmacies for a Home Medicine Review is $183.60.
Medication Review Accreditation Incentives
The Medication Review Accreditation Incentives program encourages pharmacists to become qualified to conduct medication reviews (both Residential Medication Management Reviews and Home Medicine Reviews). A total of up to $10 million for accreditation incentives is included in the funding for the Home Medicines Review program.The program aims to increase the number of accredited pharmacists and thus to improve access to medication management review services throughout Australia.
The Medication Review Accreditation Incentives comprise an initial payment of $1,500 for currently accredited pharmacists and pharmacists becoming accredited for the first time, and an annual payment of $750 for pharmacists who maintain their accreditation.
Medication Management Review Facilitator Program
The Medication Management Review Facilitator Program works through the Australian General Practice Network to promote understanding and uptake of the Home Medicine Reviews (HMR) program, and to facilitate collaboration between general practitioners and community pharmacists. Individual Divisions of General Practice are funded to employ part-time facilitators whose main responsibility is to promote the uptake of the HMR program.Up to $29 million has been allocated to this program under the Fourth Agreement.
Top of Page
